These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2877223)

  • 1. Prevention of graft failure by an anti-HLFA-1 monoclonal antibody in HLA-mismatched bone-marrow transplantation.
    Fischer A; Griscelli C; Blanche S; Le Deist F; Veber F; Lopez M; Delaage M; Olive D; Mawas C; Janossy G
    Lancet; 1986 Nov; 2(8515):1058-61. PubMed ID: 2877223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: a European Group for Immunodeficiency/European Group for Bone Marrow Transplantation report.
    Fischer A; Friedrich W; Fasth A; Blanche S; Le Deist F; Girault D; Veber F; Vossen J; Lopez M; Griscelli C
    Blood; 1991 Jan; 77(2):249-56. PubMed ID: 1985691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful haploidentical mismatched bone marrow transplantation in severe combined immunodeficiency: T cell removal using CAMPATH-I monoclonal antibody and E-rosetting.
    Morgan G; Linch DC; Knott LT; Davies EG; Sieff C; Chessells JM; Hale G; Waldmann H; Levinsky RJ
    Br J Haematol; 1986 Mar; 62(3):421-30. PubMed ID: 3513818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study.
    Straathof KC; Rao K; Eyrich M; Hale G; Bird P; Berrie E; Brown L; Adams S; Schlegel PG; Goulden N; Gaspar HB; Gennery AR; Landais P; Davies EG; Brenner MK; Veys PA; Amrolia PJ
    Lancet; 2009 Sep; 374(9693):912-20. PubMed ID: 19729196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
    Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
    Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone-marrow transplantation for immunodeficiencies and osteopetrosis: European survey, 1968-1985.
    Fischer A; Griscelli C; Friedrich W; Kubanek B; Levinsky R; Morgan G; Vossen J; Wagemaker G; Landais P
    Lancet; 1986 Nov; 2(8515):1080-4. PubMed ID: 2877234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CD25 monoclonal antibody for GVHD prophylaxis in non-T-cell depleted haploidentical bone marrow transplantation for treatment of childhood leukemia].
    Chen HR; Ji SQ; Yan HM; Wang HX; Liu J; Xue M; Zhu L
    Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):294-8. PubMed ID: 15157394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haploidentical bone marrow transplantation for severe combined immunodeficiency disease using soybean agglutinin-negative, T-depleted marrow cells.
    Cowan MJ; Wara DW; Weintrub PS; Pabst H; Ammann AJ
    J Clin Immunol; 1985 Nov; 5(6):370-6. PubMed ID: 3910675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
    Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe combined immunodeficiency: treatment by bone marrow transplantation in 15 infants using HLA-haploidentical donors.
    Friedrich W; Goldmann SF; Ebell W; Blütters-Sawatzki R; Gaedicke G; Raghavachar A; Peter HH; Belohradsky B; Kreth W; Kubanek B
    Eur J Pediatr; 1985 Jul; 144(2):125-30. PubMed ID: 3899661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency.
    Reinherz EL; Geha R; Rappeport JM; Wilson M; Penta AC; Hussey RE; Fitzgerald KA; Daley JF; Levine H; Rosen FS; Schlossman SF
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6047-51. PubMed ID: 6764536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody T-cell-depleted HLA-haploidentical bone marrow transplantation for Wiskott-Aldrich syndrome.
    Rumelhart SL; Trigg ME; Horowitz SD; Hong R
    Blood; 1990 Feb; 75(4):1031-5. PubMed ID: 2302455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-haploidentical bone marrow transplantation for severe combined immunodeficiency using E rosette fractionation and cyclosporine.
    Fischer A; Durandy A; de Villartay JP; Vilmer E; Le Deist F; Gérota I; Griscelli C
    Blood; 1986 Feb; 67(2):444-9. PubMed ID: 3510681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marrow transplantation from human leukocyte antigen-identical or haploidentical donors for correction of Wiskott-Aldrich syndrome.
    Brochstein JA; Gillio AP; Ruggiero M; Kernan NA; Emanuel D; Laver J; Small T; O'Reilly RJ
    J Pediatr; 1991 Dec; 119(6):907-12. PubMed ID: 1960605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial depleting T lymphocytes from donor marrow for matched and mismatched allogeneic bone marrow transplants.
    Trigg ME; Billing R; Sondel PM; Exten R; Hong R; Bozdech MJ; Horowitz SD; Finlay JL; Moen R; Longo W
    Cancer Treat Rep; 1985 Apr; 69(4):377-86. PubMed ID: 3888387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro analysis of donor bone marrow following monoclonal antibody treatment for the prevention of acute graft versus host disease.
    Kohler PC; Erickson C; Finlay JL; Trigg ME; Edwards B; Hong R; Hank JA; Billing R; Bozdech M; Sondel PM
    Cancer Res; 1986 Oct; 46(10):5413-8. PubMed ID: 3530439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
    Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.